Page last updated: 2024-09-05

sorafenib and endothelin-1

sorafenib has been researched along with endothelin-1 in 2 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(endothelin-1)
Trials
(endothelin-1)
Recent Studies (post-2010) (endothelin-1)
6,5207305,25112,7406323,394

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Alpini, G; Fallon, MB; Hu, B; Venter, J; Wu, W; Yang, W; Zhang, J1
Cho, EJ; Cho, KH; Hwang, CY; Kim, YJ; Lee, JH; Lee, KB; Lee, S; Noh, H; Park, SM; Suh, KS; Won, JK; Yoon, JH; Yu, SJ1

Other Studies

2 other study(ies) available for sorafenib and endothelin-1

ArticleYear
The role of receptor tyrosine kinase activation in cholangiocytes and pulmonary vascular endothelium in experimental hepatopulmonary syndrome.
    American journal of physiology. Gastrointestinal and liver physiology, 2014, Jan-01, Volume: 306, Issue:1

    Topics: Animals; Common Bile Duct; Disease Models, Animal; Endothelin-1; Endothelium, Vascular; Hepatopulmonary Syndrome; Ligation; Lung; Male; Neovascularization, Pathologic; Niacinamide; Nitric Oxide Synthase Type III; Phenylurea Compounds; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Signal Transduction; Sorafenib; Vascular Endothelial Growth Factor A

2014
Systems analysis identifies endothelin 1 axis blockade for enhancing the anti-tumor effect of multikinase inhibitor.
    Cancer gene therapy, 2022, Volume: 29, Issue:6

    Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Endothelin-1; Humans; Liver Neoplasms; Mice; Sorafenib; Systems Analysis; Xenograft Model Antitumor Assays

2022